| Date & Time | 9 January 2022 at 17.00 CEST |
|---|---|
| Address | San Francisco, USA |
| Location | Hybrid |
The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) is pleased to present the third annual Innovations in Regulatory Science Summit, a gathering of leaders in academia, industry and regulatory sectors to discuss the role of regulatory science in medical product development. The 2022 CERSI Innovations in Regulatory Science Summit will have a major focus on the use of biomarkers and endpoints in medical product development, and includes an exciting panel featuring past FDA Commissioners discussing how the COVID-19 pandemic has changed the Agency.
The event is currently envisioned as a hybrid in-person/virtual event. Registration is currently open for virtual attendance; we will provide information on registration for in-person attendance in San Francisco closer to the event date, depending on local conditions.
More information is available at https://cersisummit.com.
Registration is open here.
